User satisfaction with a smartphone-compatible, artificial intelligence-based cutaneous pigmented lesion evaluator

Chin, Yen Po Harvey; Huang, I‐Hsin; Hou, Ze Yu; Chen, Po Yu; Bassir, Fatima; Wang, Hsiao Han; Lin, Yu Ting; Li, Yu-Chuan

doi:10.1016/j.cmpb.2020.105649

Cited by 5 publications

(9 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a recent study of MoleMe, an AI cutaneous pigment evaluator developed in Taiwan, 90% of participants showed satisfaction with the app. This satisfaction was consistent across varying genders and age groups [65]. If combined with success in improving technologic healthcare equity, smartphone apps incorporating dermatologic AI could be groundbreaking in the diagnosis and care of patients via TD.…”

Section: Looking Forward: Teledermatology In a Post-covid-19 Worldmentioning

confidence: 57%

Teledermatology During COVID-19: An Updated Review

2021

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) pandemic has fundamentally transformed the landscape of providing dermatologic care. In an age of lockdowns and social distancing, teledermatology (TD) has emerged as a powerful tool to deliver remote care. Here, we review literature on TD use during the pandemic to evaluate the positives and negatives of TD implementation. We especially consider the reception of TD in underserved communities and the developing world as well as the ethico-legal challenges wrought by the burgeoning utilization of this new paradigm of care. The potential of TD to occupy a more prominent role in dermatologic care in a post-COVID-19 world is also discussed.

show abstract

Section: Looking Forward: Teledermatology In a Post-covid-19 Worldmentioning

confidence: 57%

Teledermatology During COVID-19: An Updated Review

2021

View full text Add to dashboard Cite

show abstract

“…Nine reviews [22][23][24][25][28][29][30]36,38] and one systematic review [32]; • Twenty-five papers [21,26,27,31,[33][34][35][40][41][42][43][44][45]48,[50][51][52][53][54][55][56][57][58][59][60].…”

Section: Resultsmentioning

confidence: 99%

“…The search provided 40 components [ 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 ] in the three years since the COVID-19 pandemic outbreak (at the date of this study).…”

Section: Resultsmentioning

confidence: 99%

“…In detail, the components were: Two randomized controlled (clinical) trials (RCTs) [ 37 , 49 ]; Three observational studies (OS)s [ 39 , 46 , 47 ]; Nine reviews [ 22 , 23 , 24 , 25 , 28 , 29 , 30 , 36 , 38 ] and one systematic review [ 32 ]; Twenty-five papers [ 21 , 26 , 27 , 31 , 33 , 34 , 35 , 40 , 41 , 42 , 43 , 44 , 45 , 48 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 ]. …”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Advancing Dermatological Care: A Comprehensive Narrative Review of Tele-Dermatology and mHealth for Bridging Gaps and Expanding Opportunities beyond the COVID-19 Pandemic

Giansanti

2023

Healthcare

View full text Add to dashboard Cite

Mobile health (mHealth) has recently had significant advances in tele-dermatology (TD) thanks to the developments following the COVID-19 pandemic. This topic is very important, as telemedicine and mHealth, when applied to dermatology, could improve both the quality of healthcare for citizens and the workflow in the health domain. The proposed study was centered on the last three years. We conducted an overview on the opportunities, the perspectives, and the problems involved in TD integration with mHealth. The methodology of the narrative review was based on: (I) a search of PubMed and Scopus and (II) an eligibility assessment, using properly proposed parameters. The outcome of the study showed that during the COVID-19 pandemic, TD integration with mHealth advanced rapidly. This integration enabled the monitoring of dermatological problems and facilitated remote specialist visits, reducing face-to-face interactions. AI and mobile apps have empowered citizens to take an active role in their healthcare. This differs from other imaging sectors where information exchange is limited to professionals. The opportunities for TD in mHealth include improving service quality, streamlining healthcare processes, reducing costs, and providing more accessible care. It can be applied to various conditions, such as (but not limited to) acne, vitiligo, psoriasis, and skin cancers. Integration with AI and augmented reality (AR), as well as the use of wearable sensors, are anticipated as future developments. However, integrating TD with mHealth also brings about problems and challenges related to regulations, ethics, cybersecurity, data privacy, and device management. Scholars and policymakers need to address these issues while involving citizens in the process.

show abstract

“…(2) The different evolutions and developments of the digitization of the standardization of images (DR, for example, later than the DP [ 9 , 10 , 11 , 12 ]), which is the basis of the development and implementation of AI algorithms. (3) The different roles of the patient (for example, more operator-technologists in DD, more passive in DP and DR) [ 13 , 14 ].…”

mentioning

confidence: 99%